查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413507

皮肤癌皮肤科市场：按测试项目、年龄层、设施类型划分 - 全球预测 2024-2030

Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年皮肤癌皮肤科市场规模为77.8亿美元，2024年达84.2亿美元，预计2030年将达到128.3亿美元，复合年增长率为7.40%。

全球皮肤癌皮肤科市场

主要市场统计
基准年[2023] 77.8亿美元
预测年份 [2024] 84.2亿美元
预测年份 [2030] 128.3亿美元
复合年增长率（%） 7.4%
皮肤癌皮肤科市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估皮肤癌皮肤科市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对皮肤癌皮肤病学市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-皮肤癌皮肤科市场的市场规模和预测是多少？

2-在皮肤癌皮肤科市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-皮肤癌皮肤科市场的技术趋势和法律规范是什么？

4-皮肤癌皮肤科市场主要供应商的市场占有率是多少？

5-进入皮肤癌皮肤科市场适合的型态和策略手段有哪些？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球皮肤癌发生率上升
      • 先进医疗基础设施的可用性
      • 提高大众对皮肤癌的认识
    • 抑制因素
      • 资本集中治疗
    • 机会
      • 透过引入远距皮肤病学继续发展
      • 与智慧型手机相容的诊断设备的数量正在增加。
    • 任务
      • 严格的核准和处理法规结构
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章皮肤癌皮肤科市场测试

  • 皮肤镜检查
  • 诊断影像
  • 淋巴结活检
  • 皮肤切片检查

第七章皮肤癌皮肤科市场：依年龄组

  • 0-19
  • 20-39
  • 40-59
  • 60-64
  • 65-74
  • 75-84
  • 85及以上

第八章按设施类型分類的皮肤癌皮肤科市场

  • 皮肤科组
  • 医院OPD
  • 多专科诊所
  • 独立练习

第九章北美和南美皮肤癌皮肤科市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太皮肤癌皮肤科市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲皮肤癌皮肤科市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Amgen, Inc.
    • Bristol-Myers Squibb Company
    • Canfield Scientific, Inc.
    • Colleyville Dermatology
    • Cutera, Inc.
    • FotoFinder Systems, Inc.
    • Merck & Co., Inc.
    • MetaOptima Technology Inc.
    • Novartis AG
    • Pfizer Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Sanofi SA
    • Skin Analytics Pty Ltd.
    • Speclipse, Inc.
    • Sun Pharmaceutical Industries Limited
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0360AB17E10E

[190 Pages Report] The Skin Cancer Dermatology Market size was estimated at USD 7.78 billion in 2023 and expected to reach USD 8.42 billion in 2024, at a CAGR 7.40% to reach USD 12.83 billion by 2030.

Global Skin Cancer Dermatology Market

KEY MARKET STATISTICS
Base Year [2023] USD 7.78 billion
Estimated Year [2024] USD 8.42 billion
Forecast Year [2030] USD 12.83 billion
CAGR (%) 7.4%
Skin Cancer Dermatology Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Skin Cancer Dermatology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Skin Cancer Dermatology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Skin Cancer Dermatology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Canfield Scientific, Inc., Colleyville Dermatology, Cutera, Inc., FotoFinder Systems, Inc., Merck & Co., Inc., MetaOptima Technology Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Skin Analytics Pty Ltd., Speclipse, Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Skin Cancer Dermatology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test
    • Dermatoscopy
    • Diagnostic Imaging
    • Lymph Node Biopsy
    • Skin Biopsy
  • Age Group
    • 0-19
    • 20-39
    • 40-59
    • 60-64
    • 65-74
    • 75-84
    • 85 & Above
  • Facility Type
    • Dermatology Group
    • Hospital OPD
    • Multispecialty Clinics
    • Stand Alone Practices
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Skin Cancer Dermatology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Skin Cancer Dermatology Market?

3. What are the technology trends and regulatory frameworks in the Skin Cancer Dermatology Market?

4. What is the market share of the leading vendors in the Skin Cancer Dermatology Market?

5. Which modes and strategic moves are suitable for entering the Skin Cancer Dermatology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Skin Cancer Dermatology Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of skin cancer worldwide
      • 5.1.1.2. Availability of advanced healthcare infrastructure
      • 5.1.1.3. Rising awareness about skin cancer among the population
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive treatment with therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development with introduction of teledermatology
      • 5.1.3.2. Increasing number of smartphone-compatible diagnostic devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework for the approval and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Skin Cancer Dermatology Market, by Test

  • 6.1. Introduction
  • 6.2. Dermatoscopy
  • 6.3. Diagnostic Imaging
  • 6.4. Lymph Node Biopsy
  • 6.5. Skin Biopsy

7. Skin Cancer Dermatology Market, by Age Group

  • 7.1. Introduction
  • 7.2. 0-19
  • 7.3. 20-39
  • 7.4. 40-59
  • 7.5. 60-64
  • 7.6. 65-74
  • 7.7. 75-84
  • 7.8. 85 & Above

8. Skin Cancer Dermatology Market, by Facility Type

  • 8.1. Introduction
  • 8.2. Dermatology Group
  • 8.3. Hospital OPD
  • 8.4. Multispecialty Clinics
  • 8.5. Stand Alone Practices

9. Americas Skin Cancer Dermatology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Skin Cancer Dermatology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Skin Cancer Dermatology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Amgen, Inc.
    • 13.1.3. Bristol-Myers Squibb Company
    • 13.1.4. Canfield Scientific, Inc.
    • 13.1.5. Colleyville Dermatology
    • 13.1.6. Cutera, Inc.
    • 13.1.7. FotoFinder Systems, Inc.
    • 13.1.8. Merck & Co., Inc.
    • 13.1.9. MetaOptima Technology Inc.
    • 13.1.10. Novartis AG
    • 13.1.11. Pfizer Inc.
    • 13.1.12. Regeneron Pharmaceuticals, Inc.
    • 13.1.13. Sanofi S.A.
    • 13.1.14. Skin Analytics Pty Ltd.
    • 13.1.15. Speclipse, Inc.
    • 13.1.16. Sun Pharmaceutical Industries Limited
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. SKIN CANCER DERMATOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SKIN CANCER DERMATOLOGY MARKET DYNAMICS
  • FIGURE 7. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 8. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
  • FIGURE 12. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. SKIN CANCER DERMATOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 6. SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SKIN CANCER DERMATOLOGY MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SKIN CANCER DERMATOLOGY MARKET SIZE, BY LYMPH NODE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SKIN CANCER DERMATOLOGY MARKET SIZE, BY SKIN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 11. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 0-19, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 20-39, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 40-59, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 60-64, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 65-74, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 75-84, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 85 & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY GROUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL OPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. SKIN CANCER DERMATOLOGY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. SKIN CANCER DERMATOLOGY MARKET SIZE, BY STAND ALONE PRACTICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 151. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. SKIN CANCER DERMATOLOGY MARKET LICENSE & PRICING